Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Cruciani

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
BMJ Open|December 23, 2021
Exploring the evidence for the effectiveness of health interventions for COVID-19 targeting migrants: a systematic review protocolStefania Mondello, Carmela Visalli, Firas Kobeissy, et al.
Health and Quality of Life Outcomes|February 19, 2020
Impact of polyunsaturated fatty acids on patient-important outcomes in children and adolescents with autism spectrum disorder: a systematic reviewFranco De Crescenzo, Gian Loreto D'Alò, Gian Paolo Morgano, et al.
Health and Quality of Life Outcomes|January 26, 2021
Impact of antipsychotics in children and adolescents with autism spectrum disorder: a systematic review and meta-analysisGian Loreto D'Alò, Franco De Crescenzo, Laura Amato, et al.
BMC Psychiatry|November 26, 2020
Acceptability, equity, and feasibility of using antipsychotics in children and adolescents with autism spectrum disorder: a systematic reviewGian Loreto D'Alò, Franco De Crescenzo, Laura Amato, et al.
Annali Dell'Istituto Superiore Di Sanita|December 22, 2016
A survey on lifestyle and level of biomarkers of environmental exposure in residents in Civitavecchia (Italy)Carla Ancona, Lisa Bauleo, Giovanni Biscotti, et al.
Epidemiologia E Prevenzione|December 6, 2017
Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital dataLaura Amato, Danilo Fusco, Anna Acampora, et al.
Annals of Hematology|May 21, 2013
De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened "GO question"Marino Clavio, Fabio Cruciani, Paola Minetto, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 27, 2026
From evidence to action: Italian recommendations for the diagnosis and treatment of spatial neglect in stroke patientsMauro Mancuso, Simona Vecchi, Benedetta Basagni, et al.
Annals of Hematology|July 4, 2014
Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemiaEnrico De Astis, Marino Clavio, Anna Maria Raiola, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|May 12, 2023
Italian Guidelines for the Management of ProlactinomasRenato Cozzi, Renata Simona Auriemma, Ernesto De Menis, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
BMJ Open|December 23, 2021
Exploring the evidence for the effectiveness of health interventions for COVID-19 targeting migrants: a systematic review protocolStefania Mondello, Carmela Visalli, Firas Kobeissy, et al.
Health and Quality of Life Outcomes|February 19, 2020
Impact of polyunsaturated fatty acids on patient-important outcomes in children and adolescents with autism spectrum disorder: a systematic reviewFranco De Crescenzo, Gian Loreto D'Alò, Gian Paolo Morgano, et al.
Health and Quality of Life Outcomes|January 26, 2021
Impact of antipsychotics in children and adolescents with autism spectrum disorder: a systematic review and meta-analysisGian Loreto D'Alò, Franco De Crescenzo, Laura Amato, et al.
BMC Psychiatry|November 26, 2020
Acceptability, equity, and feasibility of using antipsychotics in children and adolescents with autism spectrum disorder: a systematic reviewGian Loreto D'Alò, Franco De Crescenzo, Laura Amato, et al.
Annali Dell'Istituto Superiore Di Sanita|December 22, 2016
A survey on lifestyle and level of biomarkers of environmental exposure in residents in Civitavecchia (Italy)Carla Ancona, Lisa Bauleo, Giovanni Biscotti, et al.
Epidemiologia E Prevenzione|December 6, 2017
Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital dataLaura Amato, Danilo Fusco, Anna Acampora, et al.
Annals of Hematology|May 21, 2013
De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened "GO question"Marino Clavio, Fabio Cruciani, Paola Minetto, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 27, 2026
From evidence to action: Italian recommendations for the diagnosis and treatment of spatial neglect in stroke patientsMauro Mancuso, Simona Vecchi, Benedetta Basagni, et al.
Annals of Hematology|July 4, 2014
Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemiaEnrico De Astis, Marino Clavio, Anna Maria Raiola, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|May 12, 2023
Italian Guidelines for the Management of ProlactinomasRenato Cozzi, Renata Simona Auriemma, Ernesto De Menis, et al.
Pageof 3